Oculis Holding AGOCS
13F holders, Q4 2024 (December 31)12holders +2
3new positions
1sold out
1famous investor
$17.00avg. 13F price*
At the end of Q4 2024, 12 institutions reported holding Oculis Holding AG (OCS) in their 13F filings, up 2 from Q3 2024. 3 opened new positions and 1 sold out. The largest holders were Pivotal bioVenture Partners Investment Advisor LLC ($29.5M), Aberdeen Group plc ($17.2M) and Nan Fung Group Holdings Ltd ($7.4M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Oculis Holding AG
- CUSIP
- H5870P102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $784K |
| Exits | 1 | $12 |
All 13F filers, Q3 2024 → Q4 2024: 480,341 shares bought and 1 shares sold, net +480,340 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Pivotal bioVenture Partners Investment Advisor LLC | 19.95% | Add +8.9% | 1,737,696 | $29.5M |
| Aberdeen Group plc | 0.03% | Add +23.0% | 1,009,424 | $17.2M |
| Nan Fung Group Holdings Ltd | 6.34% | No change | 436,378 | $7.4M |
| UBS Group AG | 0.00% | Add +512.3% | 108,842 | $1.9M |
| Compagnie Lombard Odier SCmA | 0.02% | No change | 95,750 | $1.6M |
| Bank of America Corp. | 0.00% | Add +58.3% | 28,980 | $493K |
| Citadel Advisors | 0.00% | New | 22,911 | $389K |
| Geode Capital Management, LLC | 0.00% | Add +12.0% | 16,744 | $284K |
| Northern Trust Corp. | 0.00% | No change | 13,565 | $231K |
| XTX Topco Ltd | 0.02% | New | 13,249 | $225K |
| Bellevue Group AG | 0.00% | New | 10,000 | $170K |
| Dupont Capital Management Corp. | 0.00% | No change | 4 | $68 |
"% of holder's portfolio" is OCS's weight in each manager's 13F, not the share of Oculis Holding AG the manager owns.